Repositorio
Cómo publicar
Recursos
FAQs

Mostrar el registro sencillo del ítem

GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-beta

dc.contributor.authorCarrillo Gálvez, Ana Belén
dc.contributor.authorQuintero, Juan Esteban
dc.contributor.authorRodríguez González, René 
dc.contributor.authorTirados Menéndez, Sofía 
dc.contributor.authorGonzález Meana, María Victoria 
dc.contributor.authorBlanco Lorenzo, Verónica 
dc.contributor.authorAllonca Campa, Eva 
dc.date.accessioned2021-06-01T09:39:28Z
dc.date.available2021-06-01T09:39:28Z
dc.date.issued2020
dc.identifier.citationCell Death & Disease, 11(11), p. 985- (2020); doi:10.1038/s41419-020-03197-z
dc.identifier.issn2041-4889
dc.identifier.urihttp://hdl.handle.net/10651/58439
dc.description.sponsorshipThis work has been financed by the Instituto de Salud Carlos III, Spain (www.isciii.es) and Fondo Europeo de Desarrollo Regional (FEDER), from the European Union, through the research grants PI15/00794, PI18/00826, CPII15/00032 (P.A.), and PI15/02015 (F.M.). P.A. is supported by the Consejería de Salud, Junta de Andalucía through the contract “Nicolás Monardes” (C-0013-2018). A. B. C-G. was supported by the Ministerio de Ciencia y Tecnología, through the contract PEJ-2014-A-46314. This work was also supported by the Agencia Estatal de Investigación (AEI) [MICINN/Fondo Europeo de Desarrollo Regional (FEDER) (SAF-2016-75286-R to R.R.), ISCIII/FEDER [Miguel Servet Program (CPII16/00049 to R.R.), Sara Borrell Program (CD16/00103 to S-T.M.) and Consorcio CIBERONC (CB16/12/00390)]. For its collaboration, we want to acknowledge the Principado de Asturias BioBank (PT17/0015/0023), financed jointly by Servicio de Salud del Principado de Asturias, Instituto de Salud Carlos III and Fundación Bancaria Cajastur and integrated in the Spanish National Biobank Network.
dc.description.statementofresponsibilityCarrillo-Gálvez, A.B., Quintero, J.E., Rodríguez, R., Menéndez, S.T., Victoria González, M., Blanco-Lorenzo, V., Allonca, E., de Araújo Farias, V., González-Correa, J.E., Erill-Sagalés, N., Martínez-Zubiaurre, I., Hellevik, T., Sánchez-Hernández, S., Muñoz, P., Zurita, F., Martín, F., Rodríguez-Manzaneque, J.C., Anderson, P.
dc.format.extentp. 985-
dc.language.isoeng
dc.relation.ispartofCell Death & Disease
dc.rights© The Author(s) 2020
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceWOS:000595630900001
dc.titleGARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-beta
dc.typejournal article
dc.identifier.doi10.1038/s41419-020-03197-z
dc.relation.projectIDFEDER/PI15/00794
dc.relation.projectIDFEDER/PI18/00826
dc.relation.projectIDFEDER/CPII15/00032
dc.relation.projectIDFEDER/PPI15/02015
dc.relation.projectIDISCIII/FEDER/CPII16/00049
dc.relation.publisherversionhttp://dx.doi.org/10.1038/s41419-020-03197-z
dc.rights.accessRightsopen access


Ficheros en el ítem

untranslated
Nombre:
Garp.pdf
Tamaño:
6.855Mb
Formato:
PDF

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© The Author(s) 2020
Este ítem está sujeto a una licencia Creative Commons